Effect of angiopoietin 1 in a mouse model of ischemic stroke (Old ID 22799)
Principal Investigator
Stroke is the second biggest cause of mortality in Australia and has a huge socio-economic burden to the health care system. Our research aims to look at how cerebral ischemic stroke outcome can be improved. We aim to establish an animal model for cerebral ischemic stroke, explore the mechanism behind the reduction of a key protein after stroke and assess the effect this protein has in improving patient outcome. This research will provide a reproducible stoke model, establish whether our protein of interest can improve stroke outcome and help explain the mechanism behind the regulation of this protein.
09 May 2016 - 07 Nov 2016
N/A
Angiopoietin;Stroke
Queensland Government Department of Science, Information Technology and Innovation
5200
Jonathan Golledge
